Supriya Lifescience Ltd Share Price

(SUPRIYA)

Supriya Lifescience Limited is an Indian manufacturing company and supplier of active pharmaceutical ingredients (APIs). As of 31 March 2021, the company has offered 39 APIs with a focus on therapeutic segments such as antihistamines, analgesics, anaesthetics, vitamins, anti-asthmatics and anti-allergies. The company has consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India - 4555 and 6570 units, respectively - between Fiscal 2017 and 2020. Supriya Lifescience has sought approval for its products from international regulatory authorities including the USFDA, EUGMP and EDQM, and is supported by a modern manufacturing facility. Two new clean rooms are set to be powered up in the first quarter of Fiscal 2022. Over the years, the company has issued 3002400, 1626302, 9757804 Equity shares and increased its face value from Rs 10 to Rs 2 per share. In December 2021, Supriya Lifescience Limited conducted a Rs 700 crores public issue and the allotted shares were listed on BSE Ltd and NSE.

Listing date: 28 Dec, 2021
Chairperson Name: Satish Waman Wagh